24 /100
LOW RISK
Score updated May 30, 2026

BDRX — Biodexa Pharmaceuticals Plc Dilution Risk Tracker

Track BDRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BDRX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BDRX.
🔔 Track BDRX — Get forecast alerts →

💹 Market Data

Market Cap$2.59M
Shares Outstanding746.1K
FloatN/A
Cash$11.48M
Debt$82.1K
Short InterestN/A

🏛 Institutional Holdings

8 institutional holders · 63.2K shares
#1 Sabby Management, LLC 38.1K shares
#2 Armistice Capital, LLC 20.0K shares
#3 Gamma Investing LLC 2.8K shares
+ 5 more holders Sign up free to view →

📉 Short Interest

Short Interest20.9K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BDRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BDRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BDRX
📊 BDRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BDRX Signal Convergence & Dark Pool Activity — StonkWhisper 📄 BDRX Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.